POSTER SESSION II
Monday, March 26, 2007 — 1:00 PM - 4:30 PM
Convention Center, Exhibit Hall B - 1
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
...then notice the 'Event Added' prompt in the toolbar above as feedback:
TECHNIQUES
Poster#
Title and Authors
Itinerary Planner
209
15-Minute Detection of a Prostate Cancer Biomarker (AMACR) in Voided Urine Samples Using Immuno-Cantilever Sensors
(1623)
YFU Garcia, R Mutharasan - Drexel University, Philadelphia, PA; Drexel University College of Medicine, Philadelphia, PA
Comparative Evaluation of Three Assays for JAK2V617F Mutation Analysis
(1601)
C Frantz, D Sekora, D Henley, CK Huang, Q Pan, N Quigley, R Hubbard, I Mirza - University of Alberta, Edmonton, AB, Canada; Molecular Pathology Laboratory Network, Inc, Maryville, TN; Montefiore Medical Center, New York, NY
Identification of Amyloid Proteins in Formalin Fixed Paraffin Embedded Biopsy Specimens by a Novel Method Based on Mass Spectrometry Following Laser Dissection and Capture
(1642)
JA Vrana, JD Gamez, TB Plummer, HR Bergen, A Dogan - Mayo Clinic, Rochester, MN
Extraction and Amplification Methods To Enhance Expression Analysis from Formalin Fixed Paraffin Embedded Tissues
(1619)
J Li, P Smyth, S Cahill, K Denning, R Flavin, S Guenther, J O’Leary, O Sheils - Institute of Molecular Medicine, St James’ Hospital, Dublin, Ireland; Applied Biosystems, Foster City, CA
Morphology-Based Molecular Diagnosis for Targeted Cancer Therapy Using Formalin-Fixed Paraffin Embedded (FFPE) Sections
(1616)
H Kajiya, A Serizawa, H Itoh, T Minematsu, T Susumu, RY Osamura - Tokai University School of Medicine, Isehara, Kanagawa, Japan
Loss-of-Heterozygosity and Chromosome Copy Number Analysis in Paraffin Embedded Tissues Using Whole Genome SNP Arrays
(1608)
JM Hagenkord, M Lyons-Weiler, R Dhir, A Parwani, FA Monzon - University of Pittsburgh, Pittsburgh, PA
Is Formalin-Fixed Tissue Useful for Oligo-Array CGH Studies? A Comparison with Molecular Fixative
(1606)
D Gugic, M Nassiri, V Vincek, M Nadji, AR Morales - University of Miami Miller School of Medicine, Miami, FL
Changes in Antigen Density during Remission Induction in Precursor B-Cell Acute Lymphoblastic Leukemia Detected by Flow Cytometric Immunophenotyping
(1629)
MS Parab, N Ahmad, SG Fuller, JA DiGiuseppe - Hartford Hospital, Hartford, CT
Implementation of Flow Cytometry Analysis of Myeloid Populations in a High Volume Clinical Laboratory
(1626)
SA Monaghan, KD Doty, SH Swerdlow, FC Craig - University of Pittsburgh Medical Center, Pittsburgh, PA
Cytogenetic Analysis of Bone Marrow Samples Lacking Morphologic or Flow Cytometric Evidence of a Clonal Hematopoietic Process
(1605)
AJ Goodwin, HE Fremgen, ME Tang, MR Lewis - U. of Vermont & Fletcher Allen Health Care, Burlington, VT
Flow Cytometry Immunophenotypic Analysis of Anaplastic Large Cell Lymphoma
(1644)
EX Wei, JL Jorgensen, LJ Medeiros, P Lin - UT MD Anderson Cancer Center, Houston, TX
Comparison of Three Different Chromatic Dyes for the Measurement of Phosphorylated Ser727-Stat3 by Slide-Based Cytometry
(1635)
J Schwock, A Keys, JC Ho, DW Hedley, WR Geddie - University of Toronto, Toronto, ON, Canada; Cambridge, MA
Mitotic Rate by PHH3 Immunostain Is a Stronger Predictor of Metastasis in Malignant Melanoma Than Mitotic Rate by Routine H&E Stain
(1647)
KE Youens, KB Johnson, JW Turner, KR Perkinson, RT Vollmer, MA Selim - Duke University Medical Center, Durham, NC; Durham VA, Durham, NC
Her 2/neu Status in Invasive Breast Cancers Assessed by SP3: Correlation with TAB250 and FISH
(1603)
Z Ghorab, WM Hanna, HJ Kahn - University of Toronto, Toronto, ON, Canada
Membrane-Bound Peptidase Activity in Clear Cell Renal Cell Carcinoma (CCRCC)
(1598)
C Etxezarraga, A Varona, G Larrinaga, J Gil, I Hoyos, JI Lépez - Hospital de Basurto, Basque Country University (EHU/UPV), Bilbao, Bizkaia, Spain; Faculty of Medicine and Odontology and School of Nursery I, Basque Country University (EHU/UPV), Leioa, Bizkaia, Spain
The Evaluation of P504S, HMW CK and p63 Using a Triple-Antibody Cocktail with a Triple Chromogen Staining Procedure
(1638)
D Tacha, M Teixeira - Biocare Medical LLC, Concord, CA
Immunohistochemical Comparison between New Rabbit Monoclonal Antibody (SP3) and Classical Antibodies Against HER2: Correlation with Chromogenic In Situ Hybridization in Breast Cancer Tissue Microarrays
(1604)
H Gobbi, CB Nunes, RM Rocha, JS Reis-Filho, GSF Rocha, FSF Sanches, FN Oliveira - Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil; Institute of Cancer Research, London, United Kingdom
Expression of Fascin and CD10 in Uterine Spindle Cell Tumors, a Comparative Immunohistochemical Study
(1592)
AM Cano-Valdez, CB Castro Ortega, HR Dominguez-Malagon - Instituto Nacional de Cancerologia, Mexico, Distrito Federal, Mexico
Patch Tissue Microarray: A Novel Technique for Tma Construction Using Pre-Existing Slides as a Source of Tissue When Paraffin Blocks Are Unavailable
(1649)
Y Zhao, X Kong, M Ksionsk, P Lee, MB Bannan, J Melamed - New York University School of Medicine, New York, NY
Combining Different Techniques To Construct Paraffin Tissue Microarrays of Superior Quality
(1641)
UF Vogel, BD Bueltmann - University Clinic, Eberhard-Karls-University, Tuebingen, Baden-Wuerttemberg, Germany
Comparison of Fluorescence In Situ Hybridization and Immunohistochemistry for Respective MDM2 Gene Amplification and Protein Expression in Lipomatous Neoplasms
(1597)
E Downs-Kelly, J Pettay, J Weaver, S Turner, JR Goldblum, RR Tubbs - Cleveland Clinic, Cleveland, OH
button next to any title to add to Itinerary Planner...
Add
